Of note, CSPG4 (NG2) is a canonical marker of OPCs (which were previously referred to as “NG2 cells”) and is also highly expressed in a variety of gliomas, particularly in the OPC-like cellular compartment of glial malignancies. This evidence concerns the gene CSPG4 and glioma.